Evidence map›Paper›PMID 32233956›Full record

Trial reportJournal of child and adolescent psychopharmacology2020

Lisdexamfetamine Dimesylate for Preschool Children with Attention-Deficit/Hyperactivity Disorder.

Ann C Childress, Robert L Findling, James Wu, Scott H Kollins, Yi Wang, Patrick Martin, Brigitte Robertson

Open access · hybridAbstract readClinical Trial, Phase IIMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Journal of child and adolescent psychopharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Effect of amphetamines on blood pressure.The Cochrane database of systematic reviews · 2025
    Pooled it
  2. Trial
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Ann C ChildressCenter for Psychiatry and Behavioral Medicine, Las Vegas, Nevada.
Robert L FindlingDepartment of Psychiatry, Virginia Commonwealth University School of Medicine, Richmond, Virginia.
James WuBiostatistics, Shire, a member of the Takeda group of companies, Lexington, Massachusetts.
Scott H KollinsDepartment of Psychiatry and Behavioral Science, Duke University, Durham, North Carolina.
Yi WangClinical Pharmacology and Pharmacokinetics, Shire, a member of the Takeda group of companies, Lexington, Massachusetts.
Patrick MartinClinical Pharmacology and Pharmacokinetics, Shire, a member of the Takeda group of companies, Lexington, Massachusetts.
Brigitte RobertsonGlobal Clinical Development, Shire, a member of the Takeda group of companies, Lexington, Massachusetts.
Takeda (United States) · USCenter for Psychiatry and Behavioral Medicine · USDuke University · USVirginia Commonwealth University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Attention Deficit Disorder with HyperactivityCentral Nervous System StimulantsChild, PreschoolDose-Response Relationship, DrugFemaleHalf-LifeHumansLisdexamfetamine DimesylateMalePsychiatric Status Rating ScalesTreatment OutcomeCentral Nervous System StimulantsLisdexamfetamine Dimesylateattention-deficit/hyperactivity disorderclinical outcomepharmacokineticspreschool-aged childrensafetytolerability

Identifiers

PMID32233956
PMCPMC7153646
OpenAlexW3006367102

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.